首页> 外文OA文献 >Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.

【2h】

Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.

机译：对具有高21基因复发评分的ER阳性/ HER2阴性乳腺癌的阿霉素的化学敏感性：基于体外化学反应测定的研究。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sung Gwe Ahn; Soong June Bae; Changik Yoon; Yoon Jin Cha; Hak Woo Lee; Seung Ah Lee; Joon Jeong;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Chemosensitivity of ER-positive/HER2-negative breast cancers with higher 21-gene recurrence score (>= 26): a study based on in vitro chemoresponse assay [J] . Ahn S. G., Lee H. W., Lim J. W., The Breast : . 2017,第期

机译：ER阳性/ HER2阴性乳腺癌的化学敏感性具有更高的21-基因复发评分（> = 26）：基于体外化学响应测定的研究
2. Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer [J] . Poorvu Philip D., Gelber Shari I, Rosenberg Shoshana M., Journal of Clinical Oncology . 2020,第7期

机译：21-基因复发评分测定对节点阴性和节点阳性抗乳癌的少妇21-基因复发评分的预后影响
3. 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer [J] . Wen-Wen Zhang, Qin Tong, Jia-Yuan Sun, Frontiers in Oncology . 2019,第4期

机译：21基因复发评分分析无法预测T1-2 N1mic ER阳性HER2阴性乳腺癌的乳房切除术后放疗的益处
4. Prediction of Oncotype DX recurrence score in breast cancer by integration of DCE-MRI radiomics and clinicopathologic data [C] . Yajing Cui, Ming Fan, Weijun Peng, Conference on Medical Imaging: Imaging Informatics for Healthcare, Research, and Applications . 2021

机译：DCE-MRI辐射瘤和临床病理数据集成乳腺癌在乳腺癌中的癌型DX复发评分的预测
5. An Integrative Bioinformatics Approach for Developing Predictors of Recurrence for the Triple Negative and Basal Subtypes of Breast Cancer. [D] . Shahalizadeh Kalkhoran, Solmaz. 2011

机译：开发乳腺癌三阴性和基础亚型复发预测因子的综合生物信息学方法。
6. Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay [O] . Sung Gwe Ahn, Soong June Bae, Changik Yoon, 2011

机译：高21基因复发评分的ER阳性/ HER2阴性乳腺癌对阿霉素的化学敏感性：基于体外化学反应分析的研究
7. A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores [O] . Takeo Fujii, Hiroko Masuda, Yee Chung Cheng, 2021

机译：A 95基因签名分层侵袭性疾病的复发风险，具有中间体21-基因签名复发评分

Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.

著录项

引文网络

相似文献

相关主题

期刊订阅